BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression data from Fine Needle Aspiration (FNA) biopsies from breast cancer patients

Dataset: Expression data from Fine Needle Aspiration (FNA) biopsies from breast cancer patients

This is a stage-matched case control study. Cases with clinical diagnosis of Inflammatory Breast Cancer (IBC) were selected after...

Registered by ArrayExpress Uploader
View Dataset

This is a stage-matched case control study. Cases with clinical diagnosis of Inflammatory Breast Cancer (IBC) were selected after reviewing all medical records of the 440 FNA samples. IBC was defined as signs of erythema and edema (peau d’orange) involving at least one third of the skin and rapid clinical presentation. Presence of tumor emboli in the dermal lymphatics of the involved skin in the pathology report was not required for inclusion as IBC. Controls were selected to match for T stage, all T4a-c tumors in the data set were included as controls. IBC breast cancer are all T4d breast cancer. We examined if gene expression differences exist between IBC and stage-matched Non-IBC stratified according to hormone receptor and HER2 status. Pre-treatment FNA from primary tumors were obtained and RNA extracted and hybridized to Affymetrix microarrays according to manufacturer protocol.

Species:
human

Samples:
82

Source:
E-GEOD-22597

Updated:
Dec.12, 2014

Registered:
Jun.18, 2014


Factors: (via ArrayExpress)
Sample ER POSITIVE VS NEGATIVE PRECHEMO NODAL STATUS AGE HER2 POSITIVE VS NEGATIVE PRECHEMO TUMOR SIZE GRADE PRECHEMO T STAGE IBC VS NON-IBC
GSM560744 ER pos Positive 41 HER2neg 2.9 III T4b Not-IBC
GSM560743 ER pos Negative 53 HER2neg 4.1 III T4b Not-IBC
GSM560742 ER pos Positive 54 HER2neg 9 II T4d IBC
GSM56074 ER neg Positive 32 HER2neg 6.7 III T4b Not-IBC
GSM560740 ER pos Positive 67 HER2neg 11 III T4b Not-IBC
GSM560739 ER neg Positive 54 HER2pos 2.7 III T4b Not-IBC
GSM560738 ER neg Negative 51 HER2pos 4.6 III T4b Not-IBC
GSM560737 ER neg Positive 62 HER2neg NA III T4b Not-IBC
GSM560736 ER pos Positive 80 HER2pos 5 III T4b Not-IBC
GSM560735 ER pos Positive 49 HER2neg 6 III T4b Not-IBC
GSM560734 ER pos Positive 61 HER2pos 15 II T4b Not-IBC
GSM560733 ER neg Positive 68 HER2neg 4.7 III T4b Not-IBC
GSM560732 ER neg Positive 46 HER2neg 3.1 III T4b Not-IBC
GSM56073 ER neg Positive 52 HER2neg NA III T4b Not-IBC
GSM560730 ER pos Positive 46 HER2pos 7.7 III T4b Not-IBC
GSM560729 ER pos Positive 69 HER2neg 4.9 III T4b Not-IBC
GSM560728 ER neg Negative 49 HER2neg 17 III T4b Not-IBC
GSM560727 ER pos Positive 52 HER2neg 3 II T4b Not-IBC
GSM560726 ER neg Positive 50 HER2neg 5 III T4b Not-IBC
GSM560725 ER pos Positive 50 HER2neg 8.8 II T4b Not-IBC
GSM560724 ER neg Positive 46 HER2pos 3.3 III T4b Not-IBC
GSM560723 ER pos Positive 59 HER2neg 6 III T4b Not-IBC
GSM560722 ER neg Positive 73 HER2neg 3 II T4b Not-IBC
GSM56072 ER neg Positive 62 HER2neg 8 III T4b Not-IBC
GSM560720 ER pos Positive 72 HER2neg NA III T4b Not-IBC
GSM560719 ER neg Positive 60 HER2pos 12 III T4b Not-IBC
GSM560718 ER neg Positive 50 HER2neg NA III T4b Not-IBC
GSM560717 ER neg Negative 56 HER2pos 4.5 III T4c Not-IBC
GSM560716 ER neg Positive 52 HER2neg 6.9 II T4b Not-IBC
GSM560715 ER pos Positive 27 HER2pos 3.5 III T4b Not-IBC
GSM560714 ER pos Positive 64 HER2neg 4.2 II T4b Not-IBC
GSM560713 ER neg Positive 61 HER2neg 4 III T4b Not-IBC
GSM560712 ER pos Positive 24 HER2pos 7 III T4b Not-IBC
GSM5607 ER neg Positive 39 HER2neg 4.5 III T4b Not-IBC
GSM560710 ER pos Positive 58 HER2neg 6 II T4b Not-IBC
GSM560709 ER pos Positive 53 HER2neg 8 II T4b Not-IBC
GSM560708 ER pos Positive 49 HER2pos 15 III T4c Not-IBC
GSM560707 ER pos Positive 64 HER2neg 10 II T4b Not-IBC
GSM560706 ER pos Negative 49 HER2neg 4 II T4b Not-IBC
GSM560705 ER pos Positive 71 HER2pos 5.5 III T4b Not-IBC
GSM560704 ER pos Positive 46 HER2neg 6 III T4b Not-IBC
GSM560703 ER pos Negative 67 HER2neg 5 III T4b Not-IBC
GSM560702 ER neg Positive 36 HER2pos 4.2 III T4b Not-IBC
GSM56070 ER neg Positive 39 HER2pos 9 III T4b Not-IBC
GSM560700 ER pos Positive 48 HER2neg 4.9 II T4b Not-IBC
GSM560699 ER neg Positive 60 HER2neg 7.8 III T4b Not-IBC
GSM560698 ER pos Positive 53 HER2neg 3.8 II T4b Not-IBC
GSM560697 ER pos Negative 38 HER2neg 7.5 III T4b Not-IBC
GSM560696 ER pos Positive 31 HER2neg 6 III T4b Not-IBC
GSM560695 ER pos Positive 38 HER2neg 7.2 III T4b Not-IBC
GSM560694 ER neg Positive 56 HER2neg 10 III T4b Not-IBC
GSM560693 ER pos Positive 77 HER2pos 4 II T4b Not-IBC
GSM560692 ER neg Positive 51 HER2neg 10 III T4b Not-IBC
GSM56069 ER neg Positive 41 HER2neg 7 III T4b Not-IBC
GSM560690 ER neg Negative 58 HER2neg 6 III T4b Not-IBC
GSM560689 ER pos Positive 38 HER2pos 5.5 III T4b Not-IBC
GSM560688 ER neg Positive 49 HER2pos 12 III T4b Not-IBC
GSM560687 ER pos Positive 45 HER2neg 2.3 II T4d IBC
GSM560686 ER neg Positive 32 HER2neg 4 III T4d IBC
GSM560685 ER neg Positive 30 HER2pos 7 III T4d IBC
GSM560684 ER neg Positive 62 HER2neg 6 III T4d IBC
GSM560683 ER pos Positive 46 HER2neg 5 II T4d IBC
GSM560682 ER pos Positive 55 HER2neg 7.3 III T4d IBC
GSM56068 ER neg Positive 46 HER2pos 0 III T4d IBC
GSM560680 ER neg Positive 42 HER2pos 0.9 III T4d IBC
GSM560679 ER neg Positive 40 HER2neg 4 III T4d IBC
GSM560678 ER neg Positive 48 HER2neg 1.8 III T4d IBC
GSM560677 ER neg Positive 46 HER2pos 8 III T4d IBC
GSM560676 ER neg Positive 38 HER2neg 10 III T4d IBC
GSM560675 ER neg Positive 51 HER2pos 3.6 III T4d IBC
GSM560674 ER neg Positive 64 HER2neg 12.5 III T4d IBC
GSM560673 ER pos Positive 45 HER2neg 12 III T4b Not-IBC
GSM560672 ER neg Positive 55 HER2pos 1.6 III T4d IBC
GSM56067 ER pos Positive 78 HER2pos 2 III T4d IBC
GSM560670 ER neg Positive 47 HER2pos 1.6 III T4d IBC
GSM560669 ER neg Positive 45 HER2neg 4 III T4d IBC
GSM560668 ER pos Positive 32 HER2neg 3 III T4d IBC
GSM560667 ER neg Positive 58 HER2pos 3.6 III T4d IBC
GSM560666 ER neg Positive 29 HER2neg NA III T4d IBC
GSM560665 ER neg Positive 60 HER2pos 8 III T4d IBC
GSM560664 ER neg Positive 58 HER2pos 5.1 III T4d IBC
GSM560663 ER neg Positive 48 HER2pos 1.1 III T4d IBC

Tags

  • breast
  • breast cancer
  • cancer
  • hormone
  • skin

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use